Current readings: Surgical management of heart failure.
There are a myriad of surgical therapies for patients with end-stage congestive heart failure. Coronary revascularization and mitral valve repair have clear clinical benefits in appropriately selected patients. Further investigation is required before the widespread adoption of volume-reduction strategies. Cardiac stem cell therapies have yielded promising results in preclinical and phase I studies.
Department of Surgery. Duke University Medical Center, Durham, North Carolina.. Electronic address: kevin.southerland@duke.edu.
Kevin W
KW
Southerland
Carmelo A
CA
Milano
cardiac stem cells; coronary artery bypass grafting; heart failure; mitral valve repair; surgical ventricular restoration